Site management and site oversight are often used interchangeably in clinical research, but they mean different things. Explore their roles and importance in ensuring successful sites and trials.
- From Lab To Launch: Navigating The Transition To Commercial Readiness
- Working (Well) With Patient Advocates: The Sponsor POV
- Virtual Reality Endpoints Improve Measurement Of Patients' Real-World Benefit
- Working (Successfully) With Pharma: A PAG's Perspective
- The Case For Research-Naive PIs
- Making Medical Innovation Matter To Patients With Simplified Trial Design
- How Should Scientific Focus Change In 2026? Researchers Weigh In
GUEST COLUMNISTS
-
Making Medical Innovation Matter To Patients With Simplified Trial Design
To be a leader in today’s environment, Lexicon Pharmaceuticals CMO Craig Granowitz, MD, Ph.D., says companies must embrace simplified clinical trial designs, which can reduce regulatory risks, lower R&D costs, and shorten clinical timelines.
-
How Should Scientific Focus Change In 2026? Researchers Weigh In
To kick off 2026, clinical researchers share how they think research should change in the new year.
-
Researchers Want A Design Shake-Up In 2026
When asked what clinical research professionals should leave behind in 2025, quite a few lamented the stale, even problematic, approach to clinical trial design. Here's what they want done differently in 2026.
-
2026: From Experimentation To Operational Reality In Clinical Research
Velocity Clinical Research COO Nick Spittal shares several trends he sees shaping up for 2026.
-
Sales & Operations Planning for Small Teams: Aligning Clinical Supply
Small clinical teams don’t fail at S&OP from missing systems—they fail from unclear demand and decisions. Alignment comes from discipline, shared visibility, and acting on reality before timelines slip.
-
How To Meet FDA Expectations For Hybrid And Decentralized Trial Oversight
Former FDA attorney Claire Davies shares strategies for meeting regulators' expectations for hybrid and decentralized clinical trial oversight.
-
No Surprise Here: Experts Value Clinical Relevance Over Statistical Relevance
Experts weighed in: “Agree or disagree? Statistical significance is preferable to clinical relevance.”
-
Trial Matching, Source Data, And More: How Clinical Researchers Used AI In 2025
Researchers reflect on the past year and share how they used AI for clinical research in 2025.
CLINICAL TRIAL WHITE PAPERS
-
Navigating The Complexities Of Clinical Trial Site Payments Forecasting
Advanced technology and best practices have the potential to revolutionize clinical trial site payment forecasting, leading to significant improvements in overall trial efficiency and management.
-
eCOA Licensing Guide3/7/2024
In this comprehensive guide, IQVIA's eCOA library and licensing specialists, Kayla Doyle and Piero Bindi, explore five essential steps for obtaining licenses for the assessments required in your clinical trial.
-
Radiopharmaceutical Therapy: Global Clinical Trial Insights 20247/3/2024
By downloading this report, readers will uncover the transformative potential of radiopharmaceuticals in cancer therapy and stay ahead in the evolving cancer treatment landscape.
-
The True ROI Of Decentralized Clinical Trials11/13/2025
Gain a greater understanding of how the right DCT solution, or combination of solutions, coupled with clear metrics and expert guidance on execution, can demonstrate tangible, quantitative ROI in clinical trials.
-
Bladder Cancer Global Clinical Trial Landscape (2024)11/12/2024
Bladder cancer is the ninth most common cancer in the world and thirteenth in mortality. This report provides a detailed overview of the clinical trial landscape for bladder cancer.
-
Closing The Gap In Our Understanding Of Sleep Health With DHTs4/26/2024
What is the current state of sleep assessments in clinical trials, regulatory expectations, and what opportunities do wearable digital health technologies present?
CLINICAL TRIAL APP NOTES & CASE STUDIES
-
Expanding Access To Post-Market Safety Exams For Cystic Fibrosis Medication1/29/2025
This study highlights the transformative impact of point-of-need care on patient access, focusing on pediatric cystic fibrosis (CF) patients requiring essential eye exams.
-
Data Matters: Accelerating Dermatology Research With Precision!7/23/2024
When deadlines are tight, execution matters. Find out how Palleos delivered critical data packages, statistical analysis, and regulatory-ready documentation—on time and with precision!
-
Accelerate Your Oncology Breakthroughs4/16/2025
Finding the right partnership can help your oncology clinical trials overcome trial complexities through strategic planning, a deep scientific understanding, and operational excellence.
-
How Compassion Shaped This Pediatric Rare Disease Trial6/11/2025
Learn how kindness transformed the clinical trial experience for pediatric rare disease participants in a global study.
-
Fulfilling MDR Requirements For A Groundbreaking Microsurgery Robot8/19/2024
Discover the help a company pioneering the field of open surgery received to advance their robotic technology, replacing their former EDC system to improve their clinical research efficiency.
-
Pursuing Breakthrough Therapies For Rare Metabolic Diseases2/14/2024
Explore how a comprehensive clinical trial team expertly coordinated the dosing administration and data review for gene therapy, ensuring meticulous management and streamlined processes.
NEWSLETTER ARCHIVE
- 01.16.26 -- Site Management And Oversight Become Must-Haves For Success
- 01.15.26 -- 2 Expectations And 2 Warnings For The Year Ahead
- 01.14.26 -- The Rise Of Antimicrobial Resistance And Strategic Research Imperatives
- 01.14.26 -- STREAM Edition: Smarter CRO Selection And Digital Trends For 2026
- 01.13.26 -- From Experimentation To Operational Reality In Clinical Research
RECRUITMENT AND DIVERSITY
This section includes some helpful resources regarding patient recruitment and diversity in clinical trials, including this link to the FDA's guidance on diversity action plans.
-
Time is the only truly finite resource in a clinical trial. Consultant Leila Cupersmith discusses how sponsors can better design trials with a lower time burden to boost enrollment, retention, and overall operational excellence.
-
When asked what clinical research professionals should leave behind in 2025, quite a few lamented the stale, even problematic, approach to clinical trial design. Here's what they want done differently in 2026.
-
Discover how AI ambient listening has changed the way Mikel Daniels, DPM, MBA, and his team conduct clinical research at WeTreatFeet Podiatry.
FOCUS ON PATIENTS
-
Time is the only truly finite resource in a clinical trial. Consultant Leila Cupersmith discusses how sponsors can better design trials with a lower time burden to boost enrollment, retention, and overall operational excellence.
-
Aeovian CEO Allison Hulme reflects on Aeovian Pharmaceuticals' partnership with the TSC Alliance and how it’s informed research and development of their first-in-class selective mTORC1 inhibitor.
-
TSC Alliance President and CEO Kari Rosbeck details the patient advocacy group's unique and fruitful relationship with Aeovian Pharmaceuticals in developing the company's first-in-class selective mTORC1 inhibitor for TSC-related refractory epilepsy.